Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Equity (2016 - 2025)

United Therapeutics' Return on Equity history spans 16 years, with the latest figure at 0.2% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.2%; the TTM value through Dec 2025 reached 0.2%, changed 0.0%, while the annual FY2025 figure was 0.2%, 0.0% changed from the prior year.
  • Return on Equity for Q4 2025 was 0.2% at United Therapeutics, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.2% in Q4 2025 and bottomed at 0.12% in Q1 2021.
  • The 5-year median for Return on Equity is 0.17% (2023), against an average of 0.16%.
  • The largest annual shift saw Return on Equity decreased -7bps in 2021 before it increased 5bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.12% in 2021, then rose by 27bps to 0.16% in 2022, then rose by 8bps to 0.17% in 2023, then increased by 13bps to 0.19% in 2024, then rose by 2bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Return on Equity are 0.2% (Q4 2025), 0.18% (Q3 2025), and 0.18% (Q2 2025).